In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998
Rr. Reinert et al., In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998, J ANTIMICRO, 48(2), 2001, pp. 279-281
This study investigates the susceptibility to cefditoren of penicillin-susc
eptible strains of invasive Streptococcus pneumoniae (n = 312) and of penic
illin-intermediate strains of S. pneumoniae (n = 30) isolated mainly from p
atients with respiratory tract infections. The MIC(90)s of penicillin-susce
ptible and -intermediate isolates were as follows: cefditoren, less than or
equal to0.06 and 1 mg/L; penicillin G, less than or equal to0.06 and 0.5 m
g/L. Cefditoren showed the highest activity against the penicillin-intermed
iate strains investigated compared with the other beta -lactam antibiotics
and is therefore considered to be a promising agent for the treatment of in
fections caused by pneumococci with reduced penicillin susceptibility.